CCBF was established in 1952 to support the treatment of children with Mediterranean anemia, a rare, yet devastating illness. In 1944, Dr. Carl H. Smith, our founding physician and considered by many to be the father of pediatric hematology and oncology, revolutionized treatment for chronically ill children with the first successful outpatient blood transfusion.
Expanding upon Dr. Smith's vision and foresight, CCBF today supports the outstanding work of the physicians and scientists in the Division of Pediatric Hematology and Oncology at NewYork-Presbyterian Hospital Weill Cornell Medicine.
Through the Children's Cancer and Blood Foundation Clinic, the Division is a major provider of clinical services for patients with leukemia, lymphoma and other cancers, hemophilia, thalassemia, and other anemic conditions and platelet disorders. Thanks in large measure to funding from the Children's Cancer and Blood Foundation, the Division of Pediatric Hematology and Oncology remains at the forefront of advanced research and comprehensive clinical care.